NT79: A Novel Neurotensin Receptor Agonist with Selective Behavioral Effects

被引：0
|
作者：
Boules, Mona M. [1 ]
Liang, Yanqi [1 ]
Oliveros, Alfredo [1 ]
Fauq, Irfan [1 ]
Wilson, Mina [1 ]
Khaniyev, Shaheen [1 ]
Williams, Katrina [1 ]
Barbut, Denise [2 ]
Richelson, Elliott [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] Sarentis Therapeut Inc, Res, New York, NY USA
来源：
BIOLOGICAL PSYCHIATRY | 2009年 / 65卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
232
引用
收藏
页码：71S / 71S
页数：1
相关论文
共 50 条
  • [21] Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty
    Pleyer, U
    Yang, J
    Knapp, S
    Schäcke, H
    Schmees, N
    Orlic, N
    Otasevic, L
    De Ruijter, M
    Ritter, T
    Keipert, S
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (05) : 450 - 455
  • [22] Some behavioral effects of AMPA/kainate receptor agonist and antagonists
    Czlonkowska, A
    Siemiatkowski, M
    Plaznik, A
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 48 (03): : 479 - 488
  • [23] Effects of Cannabinor, a Novel Selective Cannabinoid 2 Receptor Agonist, on Bladder Function in Normal Rats
    Gratzke, Christian
    Streng, Tomi
    Stief, Christian G.
    Downs, Thomas R.
    Alroy, Iris
    Rosenbaum, Jan S.
    Andersson, Karl-Erik
    Hedlund, Petter
    EUROPEAN UROLOGY, 2010, 57 (06) : 1093 - 1100
  • [24] Neurotensin receptor-1 agonist PD 149163 modulates the lipopolysaccharide-induced behavioral disturbances in mice
    Mishra, Ankit
    Singh, K. P.
    JOURNAL OF BASIC AND APPLIED ZOOLOGY, 2024, 85 (01):
  • [25] Agonist induced conformation alteration of neurotensin receptor and the mechanism behind NA+ inhibition of 125I-NT binding
    Mitra, SP
    Carraway, RE
    Blute, R
    Luber-Narod, J
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (06): : 995 - 1021
  • [26] Cortagine: Behavioral and autonomic function of the selective CRF receptor subtype 1 agonist
    Farrokhi, Catherine Borna
    Tovote, Philip
    Blanchard, Robert J.
    Blanchard, D. Caroline
    Litvin, Yoav
    Spiess, Joachim
    CNS DRUG REVIEWS, 2007, 13 (04): : 423 - 443
  • [27] Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist
    Feifel, D
    Reza, TL
    Wustrow, DJ
    Davis, MD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 710 - 713
  • [28] In vivo Behavioral Characterization of ML417, a Novel D3 Dopamine Receptor-selective Agonist
    Akano, Emmanuel Oladele
    Moritz, Amy Elizabeth
    Preston, Michael Wayne
    Lobb, Collin Jethro
    Du Hoffmann, Johann Faustus
    Free, R. Benjamin
    Frankowski, Kevin J.
    Walters, Judith R.
    Sibley, David R.
    FASEB JOURNAL, 2018, 32 (01):
  • [29] In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier
    Kokko, KP
    Hadden, MK
    Price, KL
    Orwig, KS
    See, RE
    Dix, TA
    NEUROPHARMACOLOGY, 2005, 48 (03) : 417 - 425
  • [30] THE EFFECTS OF THE NEUROTENSIN RECEPTOR-1 AGONIST PD149163 ON ATTENTIONAL PERFORMANCE IN RATS
    Hillhouse, Todd M.
    Prus, Adam J.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E37 - E37
12345